| Literature DB >> 28848819 |
Alvar Agustí1, Peter M Calverley2, Marc Decramer3, Robert A Stockley4, Jadwiga A Wedzicha5.
Abstract
The 2011 recommendations of the Global initiative for chronic Obstructive Lung Disease (GOLD) constituted a major paradigm shift in COPD management since they set 2 major goals for the assessment and management of patients: (1) the reduction of their current level of symptoms (i.e., treat the patient today); and (2) the reduction of their risk of exacerbations (i.e., prevent them tomorrow). Exacerbations are not only an important clinical endpoint in patients with COPD, but they are also a risk factor themselves for additional adverse outcomes since they have been shown to increase the risk for mortality, to accelerate the decline in pulmonary function, and to decrease health status and quality of life. Despite their importance, many unanswered questions related to exacerbations remain. The purpose of this review is to discuss: (1)knowns and unknowns in our current understanding of exacerbations, (2) what known factors increase their risk, and (3) how to best prevent them.Entities:
Keywords: chronic bronchitis; copd; emphysema; exacerbations; inflammation; smoking; therapy
Year: 2014 PMID: 28848819 PMCID: PMC5556862 DOI: 10.15326/jcopdf.1.2.2014.0134
Source DB: PubMed Journal: Chronic Obstr Pulm Dis ISSN: 2372-952X